Skip to main content

2018 Archives

2018 Archives | 2017 Archive | 2016 Archive | 2015 Archive


Tuesday, December 04, 2018

Institute of Human Virology Researchers Discover That a Bacterial Protein Promotes Cancer

The Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) announced today the discovery that DnaK, a protein of the bacterium mycoplasma, interferes with the mycoplasma-infected cell’s ability to respond to and repair DNA damage, a known origin of cancer.


Monday, December 03, 2018

Institute of Human Virology Names Dr. Man Charurat as Director of the Center for International Health, Education, and Biosecurity

The Institute of Human Virology (IHV) at the University of Maryland School of Medicine today announced the appointment of Man E. Charurat, PhD, MHS, Professor of Medicine and Director of the Division of Epidemiology and Prevention at the IHV as the Director of IHV’s Center for International Health, Education, and Biosecurity (CIHEB). Dr. Charurat will replace Deus Bazira, DrPH, MPH, MBA. The announcement was made by Robert C. Gallo, MD, The Homer & Martha Gudelsky Distinguished Professor in Medicine, Co-Founder and Director of the IHV, and Co-Founder and Director of the Global Virus Network (GVN).


Sunday, November 11, 2018

PWID Infected With Hepatitis C Virus Can Achieve SVR Despite Imperfect Adherence to Treatment

People who inject drugs who are infected with hepatitis C virus can achieve sustained viral response, despite imperfect adherence, according to the results of a new trial. Although they are at high risk of hepatitis C virus infection and transmission, people who inject drugs tend to be excluded from treatment and coverage of treatment by health insurance because of concerns over adherence to therapy. As this population is most urgently in need of treatment, a team of investigators, led by Elana Rosenthal, MD, assistant professor of medicine in the Division of Clinical Care and Research, at the Institute of Human Virology, of the University of Maryland School of Medicine, in Baltimore, Maryland, set out to evaluate adherence in this population and determine if people who inject drugs are able to achieve cure of hepatitis C virus infection.


Tuesday, October 23, 2018

Institute of Human Virology Hosts 20th Annual International Meeting of Top Medical Virus Researchers in Baltimore, Maryland

The Institute of Human Virology (IHV) at the University of Maryland School of Medicine yesterday commenced IHV’s 20th Annual International Meeting, to be held through Thursday, October, 25 at the Four Seasons Hotel in Baltimore, Maryland. This year, among other viral and cancer related topics, the meeting is holding special sessions on the 40th anniversary of the first human retrovirus, Human T cell Leukemia Virus (HTLV), and the 15th anniversary of the President’s Emergency Plan for AIDS Relief (PEPFAR). IHV’s Annual International Meeting attracts hundreds of elite scientists who descend upon Baltimore to share ideas and inspire medical virus research collaborations.


Thursday, October 18, 2018

Officials Gather for the Grand Opening of the JACQUES Initiative Journey Center; A Community Program to Help those in Need with HIV and Hepatitis-C

U.S. Representative Elijah Cummings (D-MD) and other top officials highlighted the importance of supporting the Baltimore community at the Grand Opening of the JACQUES Initiative Journey Center. The center is part of the JACQUES Initiative , a program of the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM).


Wednesday, September 19, 2018

Institute of Human Virology (IHV) Awarded $12M to Combat Opioid Epidemic Through Clinical Research Trials

The Institute of Human Virology (IHV) at the University of Maryland School of Medicine will lead a $12 million dollar project to improve the morbidity and mortality of people with opioid use disorder (OUD). Utilizing a novel compound, IHV researches will implement a series of investigations, entitled SEARCH, to evaluate the underlying mechanisms of craving reduction as a strategy to prevent opioid misuse, dependence, and relapse. The grant is awarded through the National Institutes of Health’s (NIH) Helping to End Addiction Long-term (HEAL) Initiative, made possible through groundbreaking funding from the U.S. Congress.


Thursday, May 03, 2018

UM School of Medicine's Institute of Human Virology Makes Key Appointments to Clinical Care and Research Leadership Positions

Institute Names Dr. Shyam Kottilil and Dr. Anthony Amoroso to replace Dr. Robert Redfield, now Director at CDC.


Wednesday, April 18, 2018

Institute of Human Virology (IHV) Will Undertake Largest HIV Survey Ever Conducted in a Single Country

The Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) will lead a $100 million project to measure the reach and impact of HIV programs in Nigeria – the largest population-based HIV survey ever conducted in a single country.


Wednesday, March 21, 2018

Dr. Robert Redfield, Co-Founder of the Institute of Human Virology at the University of Maryland School of Medicine, to Become CDC Director

The Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) congratulates its co-founder and associate director, Robert R. Redfield, MD, on his appointment to be the next director of the U.S. Centers for Disease Control and Prevention (CDC).


Tuesday, March 20, 2018

UMSOM Cancer Expert at Institute of Human Virology Named Fellow of American Society of Clinical Oncology

Clement A. Adebamowo, BM, ChB, ScD, FWACS, FACS, Associate Director of Population Science at the Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine (UMSOM), and Professor of Epidemiology and Public Health, Institute of Human Virology, has been named a 2018 Fellow of the American Society of Clinical Oncology (ASCO).


Wednesday, February 28, 2018

Institute of Human Virology Adds Team of Top Cancer Immunotherapy Experts

Robert C. Gallo, MD, the Homer & Martha Gudelsky Distinguished Professor in Medicine at the UMSOM and Co-Founder & Director.of the UMSOM’s IHV, announced today that a team of leading scientists in the growing area of immune therapeutics for cancer treatment and organ transplantation, led by internationally-recognized cancer researchers Yang Liu, PhD, and Pan Zheng, MD, PhD will be joining the IHV with academic appointments in the UMSOM Department of Surgery.